Aigh Capital Management LLC Eagle Pharmaceuticals, Inc. Transaction History
Aigh Capital Management LLC
- $247 Million
- Q3 2024
A detailed history of Aigh Capital Management LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Aigh Capital Management LLC holds 1,211,509 shares of EGRX stock, worth $629,984. This represents 1.82% of its overall portfolio holdings.
Number of Shares
1,211,509
Previous 1,211,509
-0.0%
Holding current value
$629,984
Previous $6.78 Million
33.76%
% of portfolio
1.82%
Previous 2.46%
Shares
2 transactions
Others Institutions Holding EGRX
# of Institutions
70Shares Held
8.6MCall Options Held
1MPut Options Held
100-
Nantahala Capital Management, LLC New Canaan, CT2.36MShares$1.23 Million0.52% of portfolio
-
Citigroup Inc1MShares$520,2020.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA580KShares$301,3430.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT375KShares$194,9950.0% of portfolio
-
Black Rock Inc. New York, NY353KShares$183,4360.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $6.77M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...